ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) |
Title of each class |
Trading Symbol |
Name of each exchange on which registered | ||
Common Shares, no par value |
AKU |
The Toronto Stock Exchange |
Large accelerated filer | ☐ | ☒ | ||||
Non-accelerated filer |
☐ | Smaller reporting company | ||||
Emerging growth company |
Auditor PCAOB ID Number: |
Auditor Name: |
Auditor Location: |
Page |
||||||
Item 10. |
1 |
|||||
Item 11. |
5 |
|||||
Item 12. |
15 |
|||||
Item 13. |
16 |
|||||
Item 14. |
17 |
|||||
Item 15. |
18 |
|||||
19 |
Item 10. |
Directors, Executive Officers and Corporate Governance |
Name |
Age |
Position(s) | ||
Executive Officers |
||||
Riadh Zine | 50 | Chairman of the Board of Directors, Chief Executive Officer and Director | ||
William Larkin | 52 | Chief Financial Officer | ||
Matthew Cameron | 40 | Chief Legal Officer and Corporate Secretary | ||
Paul Nelis | 54 | Chief Information Officer | ||
Douglas McCracken | 53 | President, Oncology | ||
Laurie Miller | 55 | Chief Human Resources Officer | ||
Tracy Wiese | 53 | Chief Strategy & Marketing Officer | ||
Gina Bonica-Delgado | 45 | General Counsel, Chief Risk Officer and Assistant Secretary | ||
Holly Huso | 58 | Enterprise Sales Officer | ||
Rohit Navani | 45 | Executive Vice President and Chief Transformation Officer | ||
Non-Employee Directors |
||||
Stanley Dunford | 73 | Chairperson Emeritus of the Board of Directors and Director | ||
Murray Lee | 62 | Director, Lead Independent Director | ||
James Webb | 62 | Director | ||
Thomas Davies | 63 | Director | ||
Haichen Huang | 28 | Director | ||
Paul Viviano | 69 | Director | ||
James Wyper | 32 | Director |
Item 11. |
Executive Compensation |
• | Riadh Zine, our Chief Executive Officer; |
• | Rhonda Longmore-Grund, our former Co-Chief Executive Officer; |
• | Rohit Navani, our Executive Vice President and Chief Transformation Officer; and |
• | Matthew Cameron, our Chief Legal Officer and Corporate Secretary. |
Name and Principal Position |
Year |
Salary ($) (1) |
Bonus ($) |
Stock Awards ($) (4) |
Nonequity Incentive Plan Compensation ($) |
All Other Compensation ($) (5) |
Total ($) |
|||||||||||||||||||||
Riadh Zine |
2021 | 662,500 | 1,300,000 | (2) |
1,521,000 | — | 9,600 | 3,493,100 | ||||||||||||||||||||
Chief Executive Officer |
2020 | 510,000 | 750,000 | (3) |
1,178,100 | — | 3,200 | 2,441,300 | ||||||||||||||||||||
Rhonda Longmore-Grund |
2021 | 252,698 | — | 169,000 | 78,449 | (6) |
— | 500,147 | ||||||||||||||||||||
Former Co-Chief Executive Officer |
||||||||||||||||||||||||||||
Rohit Navani |
2021 | 411,540 | 200,000 | (2) |
84,500 | — | 29,800 | 725,840 | ||||||||||||||||||||
Executive Vice President and Chief Transformation Officer |
2020 | 355,385 | 330,000 | (3) |
285,600 | — | 15,877 | 986,862 | ||||||||||||||||||||
Matthew Cameron |
2021 | 261,150 | 250,000 | (2) |
169,000 | — | 12,520 | 692,670 | ||||||||||||||||||||
Chief Legal Officer and Corporate Secretary |
2020 | 187,384 | 100,000 | (3) |
142,800 | — | 5,858 | 436,043 |
(1) | As part of the Company’s cost containment strategy in connection with the COVID-19 pandemic, the salary payable to each of our NEOs (other than Ms. Longmore-Grund) was reduced by 20% from approximately April 1, 2020 through December 31, 2020. |
(2) | Amounts reflect extraordinary transaction-related compensation awarded in connection with the Alliance Acquisition. No discretionary annual cash bonus was awarded for Fiscal 2021. |
(3) | Amounts reflect annual cash bonus awards paid by the Company during or in respect of Fiscal 2020. |
(4) | RSUs awarded to Mr. Zine, Mr. Navani, and Mr. Cameron for Fiscal 2021 were awarded as part of extraordinary transaction-related compensation given in connection with the Alliance Acquisition. |
(5) | Amounts in this column reflect other compensation granted during or in respect of the given fiscal year, which (a) for Mr. Zine consists of car allowance payments of $9,600 and $3,200 for Fiscal 2021 and Fiscal 2020, respectively, (b) for Mr. Navani consists of $24,000 in car allowance and $5,800 in 401(k) employer-matching contributions for Fiscal 2021 and $13,200 of car allowance payments and $2,677 in 401(k) employer-matching contributions for Fiscal 2020, and (c) for Mr. Cameron consists of $6,720 in car allowance payments and $5,800 in 401(k) employer-matching contributions for Fiscal 2021 and $3,920 in car allowance payments and $1,938 in 401(k) employer-matching contributions for Fiscal 2020. As part of the Company’s cost containment strategy in connection with the COVID-19 pandemic, car allowance payments were suspended for each of the NEOs from April 1, 2020 through August 30, 2020. |
(6) | Amounts awarded pursuant to a management incentive plan established by Alliance for Fiscal 2021 with respect to the period from September 1, 2021 to December 31, 2021. |
• on or after the first anniversary of the date of grant: 34%; |
• on or after the second anniversary of the date of grant: 33%; and |
• on or after the third anniversary of the date of grant: 33%. |
Event Provisions |
Provisions | |
Termination for Cause | All vested and unvested options held by the holder will immediately terminate and become null, void and of no effect on the date on which Akumin gives notice of termination for cause. | |
Ceasing to be a (non-executive) Director |
The expiry date for options that had vested on the date such holder ceases to be a director will be the earlier of the expiry date shown on the relevant grant agreement and the date that is 180 days following the date such holder ceases to be an eligible participant (as a result of his or her ceasing to be a director of the Company). Options which are outstanding but unvested on the date such holder ceases to be a director will immediately terminate and become null, void and of no effect. | |
Voluntary Resignation or Termination without Cause | The expiry date for options that had vested on the date such holder voluntarily resigns or is terminated by the Company without cause will be the earlier of the expiry date shown on the relevant grant agreement and the date which is 30 days following the date such holder ceases to be an eligible participant (as a result of his or her voluntary resignation or termination without cause). Options which are outstanding but unvested on the date such holder voluntary resigns or is terminated by the Company without cause will immediately terminate and become null, void and of no effect. | |
Disability | The Board may in its discretion determine that a holder with a disability shall no longer be an eligible participant. If so, the expiry date for options that had vested on the date such holder ceases to be an eligible participant will be the earlier of the expiry date shown on the relevant grant agreement and the date which is 180 days following the date such holder ceases to be an eligible participant. Options which are outstanding but unvested on the date such holder ceases to be an eligible participant will immediately terminate and become null, void and of no effect. | |
Retirement | The expiry date for options that had vested on the date such holder ceases to be an eligible participant as a result of his or her retirement in accordance with the Company’s then applicable retirement policy or a determination of the Board will be the earlier of the expiry date shown on the relevant grant agreement and the date which is 180 days following the date such holder ceases to be an eligible participant. Options which are outstanding but unvested on the date such holder ceases to be an eligible participant will immediately terminate and become null, void and of no effect. | |
Death | The expiry date for options that had vested immediately prior to the death of the holder will be the earlier of the expiry date shown on the relevant grant agreement and the date which is 180 days after the date of such holder’s death. Options that are outstanding but unvested immediately prior to the holder’s death will immediately terminate and become null, void and of no effect upon the death of the holder. |
a) | assume any option outstanding under the Option Plan on substantially the same economic terms and conditions as the Option Plan; or |
b) | substitute or replace similar stock options (including an award to acquire the same consideration paid to the securityholders of the Company as part of the change of control transaction) for those options outstanding under the Option Plan on substantially the same economic terms and conditions as the Option Plan. |
• | 1 ⁄2 of the RSUs granted shall vest on the first anniversary of the date of grant; and |
• | 1 ⁄2 of the RSUs granted shall vest on the second anniversary of the date of grant. |
Event Provisions |
Provisions | |
Termination for Cause |
All unvested RSUs expire on the termination date and are of no further force or effect and such holder shall no longer be eligible for a grant of RSUs. | |
Ceasing to be a (non-executive) Director |
All unvested RSUs will vest and shall be settled as soon as practicable following the vesting date. | |
Termination other than for Cause |
All unvested RSUs will vest and shall be settled as soon as practicable following the vesting date. | |
Disability |
All unvested RSUs will vest and shall be settled as soon as practicable following the vesting date. | |
Retirement |
All unvested RSUs will vest and shall be settled as soon as practicable following the vesting date. | |
Death |
All unvested RSUs will vest and shall be settled as soon as practicable following the vesting date. |
Option Awards |
Stock Awards |
|||||||||||||||||||||||||||
Name |
Grant Date |
Number of Securities Underlying Unexercised Options Exercisable |
Number of Securities Underlying Unexercised Options Unexercisable (1) |
Option Exercise Price ($) |
Option Expiration Date |
Number of Shares or Units of Stock That Have Not Vested (#) (2) |
Market Value of Shares or Units of Stock That Have Not Vested ($) (3) |
|||||||||||||||||||||
Riadh Zine |
3/15/16 |
825,268 |
— |
0.50 |
3/15/26 |
|||||||||||||||||||||||
Co-Chief Executive Officer |
11/16/18 |
875,000 |
— |
3.74 |
11/16/25 |
|||||||||||||||||||||||
11/18/19 |
566,820 |
279,180 |
(4) |
3.29 |
11/18/26 |
|||||||||||||||||||||||
3/9/21 |
330,000 |
(5) |
577,500 |
|||||||||||||||||||||||||
12/17/21 |
900,000 |
(6) |
1,575,000 |
|||||||||||||||||||||||||
Rhonda Longmore-Grund |
12/17/21 |
— |
— |
— |
— |
100,000 |
(7) |
175,000 |
||||||||||||||||||||
Former Co-Chief Executive Officer |
||||||||||||||||||||||||||||
Rohit Navani |
3/15/16 |
400,000 |
— |
0.50 |
3/15/26 |
|||||||||||||||||||||||
Executive Vice President and Chief Transformation Officer |
11/16/18 |
325,000 |
— |
3.74 |
11/16/25 |
|||||||||||||||||||||||
11/18/19 |
147,400 |
72,600 |
(8) |
3.29 |
11/18/26 |
|||||||||||||||||||||||
3/9/21 |
80,000 |
(9) |
140,000 |
|||||||||||||||||||||||||
12/17/21 |
50,000 |
(10) |
87,500 |
|||||||||||||||||||||||||
Matthew Cameron |
11/16/18 |
100,000 |
— |
3.74 |
11/16/25 |
|||||||||||||||||||||||
Chief Legal Officer and Corporate Secretary |
11/18/19 |
46,900 |
23,100 |
(11) |
3.29 |
11/18/26 |
||||||||||||||||||||||
3/9/21 |
40,000 |
(12) |
70,000 |
|||||||||||||||||||||||||
12/17/21 |
100,000 |
(13) |
175,000 |
(1) |
Amounts in this column reflect stock options granted which have not yet vested in accordance with the terms of our Option Plan and therefore may not yet be exercised for common shares. | |
(2) |
Amounts in this column reflect RSUs granted that have not yet vested in accordance with the terms of our Option Plan and therefore may not yet be settled for common shares. | |
(3) |
Based on the closing sale price of our common stock on NASDAQ of $1.75 per share on December 31, 2021. | |
(4) |
Approximately 67% of the common shares subject to this option were vested as of December 31, 2021, and the remaining 33% will vest on November 18, 2022. | |
(5) |
Approximately 50% of the RSUs vested on March 9, 2022, and the remaining 50% will vest on March 9, 2023. | |
(6) |
Approximately 50% of the RSUs will vest on December 17, 2022, and the remaining 50% will vest on December 17, 2023. | |
(7) |
Approximately 50% of the RSUs will vest on December 17, 2022, and the remaining 50% will vest on December 17, 2023. | |
(8) |
Approximately 67% of the common shares subject to this option were vested as of December 31, 2021, and the remaining 33% will vest on November 18, 2022. | |
(9) |
Approximately 50% of the RSUs vested on March 9, 2022, and the remaining 50% will vest on March 9, 2023. | |
(10) |
Approximately 50% of the RSUs will vest on December 17, 2022, and the remaining 50% will vest on December 17, 2023. | |
(11) |
Approximately 67% of the common shares subject to this option were vested as of December 31, 2021, and the remaining 33% will vest on November 18, 2022. | |
(12) |
Approximately 50% of the RSUs vested on March 9, 2022, and the remaining 50% will vest on March 9, 2023. | |
(13) |
Approximately 50% of the RSUs will vest on December 17, 2022, and the remaining 50% will vest on December 17, 2023. |
Name |
Fees Earned or Paid in Cash ($) (1) |
Stock Awards ($) (2) |
Option Awards ($) (3)(4) |
All Other Compensation ($) |
Total ($) |
|||||||||||||||
Stanley Dunford |
72,500 |
— |
74,999 |
— |
147,499 |
|||||||||||||||
Murray Lee |
72,500 |
— |
74,999 |
— |
147,499 |
|||||||||||||||
James Webb |
65,000 |
— |
74,999 |
— |
139,999 |
|||||||||||||||
Thomas Davies |
72,500 |
— |
74,999 |
1,132 |
148,630 |
|||||||||||||||
Haichen Huang |
16,667 |
— |
— |
— |
16,667 |
|||||||||||||||
Paul Viviano |
4,167 |
— |
— |
— |
4,167 |
|||||||||||||||
James Wyper |
4,167 |
— |
— |
— |
4,167 |
(1) |
Amounts in this column reflect cash paid to each non-executive director as described below for positions held. Mr. Dunford served as chair until August 30, 2021 and chairman emeritus from September 1, 2021 until December 31, 2021. Mr. Lee served as lead independent director, chairman of the compensation and governance committees and a member of the audit committee. Mr. Webb served as a member of the audit, compensation and governance committees. Mr. Davies served as chair of the audit committee and a member of the compensation and governance committees. Mr. Huang was appointed to the board on September 1, 2021 upon closing of the Alliance Acquisition and cash compensation reflects pro rata annual cash based on time served. Mr. Viviano and Mr. Wyper were appointed to the board upon their election at a special meeting of shareholders held November 23, 2021 and cash compensation reflects pro rata annual cash based on time served. | |
(2) |
As of December 31, 2021, the aggregate number of stock awards held by each non-employee director was as follows: Stanley Dunford – 21,008; Murray Lee – 21,008; James Webb – 21,008; Thomas Davies – 21,008; Haichen Huang – 0; Paul Viviano – 0; and James Wyper – 0. | |
(3) |
The amounts reported do not reflect the amounts actually received by our NEOs. Instead, in accordance with SEC rules, these amounts reflect the grant date fair value of each stock option granted to our NEOs during Fiscal 2021, as computed in accordance with Financial Accounting Standard Board Accounting Standards Codification Topic 718 for stock-based compensation transactions (“FASB ASC 718”). Assumptions used in the calculation of these amounts are included in Note 14 to our audited financial statements included in the Original Filing. As required by SEC rules, the amounts shown exclude the impact of estimated forfeitures related to service-based vesting conditions. Our directors who have received options will only realize compensation with regard to these options to the extent the trading price of our common stock is greater than the exercise price of such options. | |
(4) |
As of December 31, 2021, the aggregate number of stock options held by each non-employee director was as follows: Stanley Dunford – 252,213; Murray Lee – 102,213; James Webb – 102,213; Thomas Davies – 252,213; Haichen Huang – 0; Paul Viviano – 0; and James Wyper – 0. |
Type of Fee |
Position |
Amount (1) | ||
Board of Directors |
Chair (cash compensation; non-executive only) Board Member (cash compensation) Chair and Board Member (incentive compensation) |
$72,500/year $50,000/year (2) $75,000/year (3) | ||
Audit Committee |
Chair Member |
$15,000/year $7,500/year (4) | ||
Governance Committee |
Chair Member |
$7,500/year $3,750/year (5) | ||
Compensation Committee |
Chair Member |
$7,500/year $3,750/year (6) | ||
Meeting Fees |
Out of province travel for Board meetings (as applicable) |
$2,500/meeting plus reimbursement of expenses |
(1) |
Represents compensation paid per year to each non-executive director. Any cash compensation was paid on a fiscal quarterly basis, in arrears. |
(2) |
Such compensation was paid to non-executive members of the Board other than the Chair. Amounts due to the Chairman Emeritus were equal to payments due to the Chair. |
(3) |
Annual incentive compensation per director ($75,000/year) was paid by the issuance of 52,213 options with respect to the 2020 fiscal year on November 18, 2019 under our Option Plan dated November 14, 2017 with a value of $1.4364 per option calculated using the Black-Scholes valuation method determined on the date of grant, reflecting a market and exercise price of $3.29 per Common Share, a term of 7 years, a volatility rate of 40.26%, an annual risk free interest rate of 1.48% and no dividends. Directors must serve on the date of grant to be eligible for equity-based compensation. |
(4) |
Such compensation was paid to members of the Audit Committee other than the Chair of the Audit Committee. |
(5) |
Such compensation was paid to members of the Governance Committee other than the Chair of the Governance Committee. |
(6) |
Such compensation was paid to members of the Compensation Committee other than the Chair of the Compensation Committee. |
Item 12. |
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters |
Beneficial |
Ownership |
Common shares beneficially owned |
||||||||
Name and address of beneficial owner |
Number |
Percentage |
||||||
5% stockholders: |
||||||||
Nantahala Capital Management, LLC (1) |
6,320,740 |
7.06 |
% | |||||
SCW Capital Management, LP (2) |
11,419,908 |
12.76 |
% | |||||
Stonepeak Magnet Holdings LP (3)(4) |
20,614,093 |
19.33 |
% | |||||
Thaihot Investment Co., LTD (5) |
14,223,570 |
15.89 |
% | |||||
Directors and named executive officers: |
||||||||
Rohit Navani (6) |
1,721,393 |
1.90 |
% | |||||
Matthew Cameron (7) |
218,409 |
* |
||||||
Riadh Zine (8) |
6,883,976 |
7.50 |
% | |||||
Rhonda Longmore-Grund (9) |
100,000 |
* |
||||||
Stanley Dunford (10) |
5,521,611 |
6.15 |
% | |||||
James Webb (11) |
1,998,861 |
2.23 |
% | |||||
Murray Lee (12) |
266,816 |
* |
||||||
Thomas Davies (13) |
262,316 |
* |
||||||
James Wyper |
— |
* |
||||||
Paul Viviano |
— |
* |
||||||
Haichen Huang |
— |
* |
||||||
All executive officers and directors as a group (18 persons) |
16,974,382 |
18.17 |
% |
* |
Represents less than 1%. | |
(1) |
Wilmot B. Harkey and Daniel Mack are the managing members of Nantahala Capital Management, LLC and, as such, may be deemed to be the beneficial owners of the common shares. The address for Nantahala Capital Management, LLC is 130 Main St. 2nd Floor, New Canaan, CT 06840. | |
(2) |
SCW Capital, LP, SCW Capital QP, LP, SCW Single-Asset Partnership, LP, SCW Single-Asset Partnership QP, LP (together, the “Funds”), Robert N. Cathey, G. Stacy Smith and John R. Wagner are the record and direct beneficial owners of the common shares. SCW Capital Management, LP serves as investment manager to, and may be deemed to beneficially own securities owned by, each of the Funds. Trinity Investment Group, LLC serves as general partner to, and may be deemed to beneficially own securities owned by, each of the Funds and SCW Capital Management, LP. The address for SCW Capital Management, LP is 3131 Turtle Creek Blvd., Suite 302, Dallas, Texas 75219. |
(3) |
Stonepeak Magnet Holdings LP, Stonepeak Associates IV LLC, Stonepeak Associates IV LLC, Stonepeak GP Investors Manager LLC and Michael Dorrell are the record and direct beneficial owners of the common shares. Stonepeak Associates IV LLC is the sole general partner of Stonepeak Magnet Holdings LP. Stonepeak GP Investors IV LLC is the sole member of Stonepeak Associates IV LLC. Stonepeak GP Investors Manager LLC is the managing member of Stonepeak GP Investors IV LLC. Mr. Dorrell is the managing member of Stonepeak GP Investors Manager LLC. The address for SCW Capital Management, LP is 55 Hudson Yards, 550 W. 34th Street, 48th Floor, New York, New York 10001. | |
(4) |
Includes 17,114,093 common shares that Stonepeak Magnet Holdings LP has the right to acquire pursuant to the exercise of warrants. | |
(5) |
The address for Thaihot Investment Co., LTD is 18201 Von Karman Avenue, #600, Irvine, CA 92612. | |
(6) |
Consists of (i) 847,619 common shares held directly by Mr. Navani, (ii) 1,374 common shares held in a 401(k) plan, and (iii) 872,400 common shares issuable within 60 days of April 11, 2022 upon exercise of stock options to purchase common shares. | |
(7) |
Consists of (i) 45,100 common shares held directly by Mr. Cameron, (ii) 25,000 common shares held through a registered retirement savings plan, (iii) 1,409 common shares held in a 401(k) plan, and (iv) 146,900 common shares issuable within 60 days of April 11, 2022 upon exercise of stock options to purchase common shares. | |
(8) |
Consists of (i) 4,566,888 common shares held directly by Mr. Zine, (ii) 50,000 common shares held through a registered retirement savings plan, and (iii) 2,267,088 common shares issuable within 60 days of April 11, 2022 upon exercise of stock options to purchase common shares. | |
(9) |
Consists of 100,000 common shares issued upon conversion of RSUs that vested on March 18, 2022 and settled for common shares on March 23, 2022 in connection with the termination of Ms. Longmore-Grund’s employment with the Company. | |
(10) |
Consists of (i) 26,703 common shares held directly by Mr. Dunford, (ii) 5,162,135 common shares held directly by Floyd Dunford Limited, an Ontario Corporation of which Mr. Dunford is the sole controlling holder, (iii) 97,790 common shares held directly by Dunford Marine Holdings LP, an Ontario limited partnership of which Mr. Dunford is the sole controlling holder, and (iv) 234,983 common shares issuable within 60 days of April 11, 2022 upon exercise of stock options to purchase common shares. Mr. Dunford has pledged 5,162,135 common shares to a financial institution. | |
(11) |
Consists of (i) 27,333 common shares held directly by Mr. Webb, (ii) 300,000 common shares held by LK Family Limited Partnership, of which Mr. Webb exercises voting rights and has the right to dispose of such shares, (iii) 1,586,545 common shares held directly by Laurel Enterprises, LLC, of which Mr. Webb exercises voting rights and has the right to dispose of such shares, and (iv) 84,983 common shares issuable within 60 days of April 11, 2022 upon exercise of stock options to purchase common shares. | |
(12) |
Consists of (i) 177,333 common shares held directly by Mr. Lee, (ii) 4,500 common shares held by trusts for the benefit of Mr. Lee’s family, of which Mr. Lee is a trustee and has sole voting and dispositive power with respect to such shares, and (iii) 84,983 common shares issuable within 60 days of April 11, 2022 upon exercise of stock options to purchase common shares. | |
(13) |
Consists of (i) 27,333 common shares held directly by Mr. Davies and (ii) 234,983 common shares issuable within 60 days of April 11, 2022 upon exercise of stock options to purchase common shares. |
Plan category |
Number of securities to be issued upon exercise of outstanding options, warrants and rights |
Weighted-average exercise price of outstanding options, warrants and rights (2) |
Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column (a)) |
|||||||||
Equity (1) |
7,709,152 |
$ |
1.87 |
1,193,547 |
||||||||
Equity compensation plans not approved by security holders |
— |
— |
— |
|||||||||
|
|
|
|
|
|
|||||||
Total |
7,709,152 |
$ |
1.87 |
1,193,547 |
(1) |
Total reflects outstanding stock options and RSUs granted pursuant to our Option Plan and RSU Plan. | |
(2) |
The weighted-average exercise price does not reflect the common shares that will be issued in connection with the settlement of RSUs, since RSUs have no exercise price. |
Item 13. |
Certain Relationships and Related Transactions, and Director Independence |
Item 14. |
Principal Accountant Fees and Services |
Fiscal year ended December 31, |
||||||||
2021 |
2020 |
|||||||
Audit fees (1) |
$ | 2,846,000 | $ | 1,400,533 | ||||
Audit-related fees (2) |
$ | 245,000 | — | |||||
Tax fees (3) |
$ | 114,900 | — | |||||
All other fees |
— | — | ||||||
|
|
|
|
|||||
Total fees |
$ |
3,205,900 |
$ |
1,400,533 |
||||
|
|
|
|
(1) | “ Audit fees | |
(2) | “ Audit-related fees | |
(3) | “ Tax fees |
(a) | The following documents are filed as part of, or are incorporated by reference into, this Amendment No. 1: |
AKUMIN INC. | ||
By: | /s/ Riadh Zine | |
Riadh Zine Chairman, Chief Executive Officer and Director |
Signature |
Title |
Date | ||
/s/ Riadh Zine Riadh Zine |
Chairman, Chief Executive Officer and Director (Principal Executive Officer) |
April 11, 2022 | ||
/s/ William Larkin William Larkin |
Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer) |
April 11, 2022 | ||
* Stan Dunford |
Chairperson Emeritus of the Board of Directors and Director | April 11, 2022 | ||
* Murray Lee |
Director | April 11, 2022 | ||
* |
Director | April 11, 2022 | ||
James Webb | ||||
* Thomas Davies |
Director | April 11, 2022 | ||
* |
Director | April 11, 2022 | ||
Haichen Huang | ||||
* Paul Viviano |
Director | April 11, 2022 | ||
* James Wyper |
Director | April 11, 2022 |
*By: | /s/ Riadh Zine Riadh Zine, Attorney-in-Fact |
April 11, 2022 |